Glaukos is an ophthalmic medical technology and pharmaceutical company that develops therapies for treating glaucoma, corneal disorders, and retinal diseases. It offers various products including iStent inject W, a tool for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate primary open-angle glaucoma; iStent infinite, an implantable device intended to reduce IOP of the eye; iAccess Precision Blade; which minimizes tissue disruption and is designed to preserve the eye’s natural blood-aqueous barrier; etc. The company also provides iLink Corneal Cross-Linking, a therapy that creates corneal collagen cross-links, shortens and thickens collagen fibrils, and stiffens the cornea.